Literature DB >> 7073117

Pulmonary arterial and alveolar development in normal postnatal rat lung.

B Meyrick, L Reid.   

Abstract

The postnatal development of rat lung was studied by quantitative light microscopic techniques at 12 hours and at 3, 8, 11, 15, 22, and 36 days of age. Particular emphasis was placed on the pulmonary arterial circulation. At birth the lung is not the adult lung in miniature; adaptation occurs through a series of relatively fast steps. A spurt of alveolar multiplication occurs between 3 and 8 days of age, followed, between 8 and 11 days, by one of arterial multiplication. Muscular, partially muscular, and nonmuscular arteries are present within the acinus from birth and their proportion, in each intra-acinar region, is similar at all ages examined except in the alveolar wall where muscular arteries are not found before 11 days of age. Between 12 hours and 8 days, medial thickness of the intra-acinar arteries decreases. At about 15 days of age this decrease is followed, in both pre-acinar and intra-acinar regions, by an increase in medial thickness. Between 12 hours and 3 days, absolute weight of the right ventricle decreases. This pattern of growth indicates that, at certain times, lung development is especially susceptible to injury and, also, that the nature of the disturbance is determined by its timing.

Entities:  

Mesh:

Year:  1982        PMID: 7073117     DOI: 10.1164/arrd.1982.125.4.468

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Transition from placental to air breathing stimulates haem-oxygenase-1 expression without functional consequence for pulmonary vascular adaptation in pigs and mice.

Authors:  Salome J Stanford; Alison A Hislop; Ute Oltmanns; Elizabeth G Nabel; Hong Sang; Shelia G Haworth; Jane A Mitchell
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

2.  Pulmonary vasculature changes associated with idiopathic closure of the ductus arteriosus and hydrops fetalis.

Authors:  G J Downing; D W Thibeault
Journal:  Pediatr Cardiol       Date:  1994 Mar-Apr       Impact factor: 1.655

3.  Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia.

Authors:  Jack Gauldie; Tom Galt; Philippe Bonniaud; Clinton Robbins; Margaret Kelly; David Warburton
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung.

Authors:  Angela K Ormerod; Zhenlan Xing; Nancy G Pedigo; Anjali Mishra; David M Kaetzel
Journal:  Exp Lung Res       Date:  2008-05       Impact factor: 2.459

5.  Soluble guanylate cyclase modulates alveolarization in the newborn lung.

Authors:  Patricia R Bachiller; Katherine H Cornog; Rina Kato; Emmanuel S Buys; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

6.  Structural and molecular regulation of lung maturation by intratracheal vascular endothelial growth factor administration in the normally grown and placentally restricted fetus.

Authors:  Erin V McGillick; Sandra Orgeig; Janna L Morrison
Journal:  J Physiol       Date:  2015-12-23       Impact factor: 5.182

Review 7.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

8.  Recombinant adiponectin protects the newborn rat lung from lipopolysaccharide-induced inflammatory injury.

Authors:  Julijana Ivanovska; Na-Young Cindy Kang; Nikola Ivanovski; Avita Nagy; Jaques Belik; Estelle B Gauda
Journal:  Physiol Rep       Date:  2020-09

9.  Presence of N-acetylgalactosamine/galactose residues on bronchioloalveolar cells during rat postnatal development.

Authors:  Maria de Fátima Martins; Paula Martins; Carlos Alberto Gonçalves
Journal:  Eur J Histochem       Date:  2019-09-11       Impact factor: 3.188

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.